Data & Sample Sharing
It is important to share data that cannot be readily replicated. We believe data should be made as widely and freely available as possible while safeguarding the privacy of participants and protecting confidential and proprietary data.
In 2012, API established a precedent-setting agreement with Genentech and its parent organization, Roche, to share data and biological samples from the API ADAD Colombia Trial.
API subsequently established similar data and biological sample-sharing agreements with Novartis and Amgen for the Generation Program.
In 2016, API researchers, along with their colleagues from the Collaboration for Alzheimer’s Prevention (CAP), developed data and sample sharing principles to ensure trials can be performed in ways that will have the greatest public benefit. API intends to embrace these principles in all its trials and studies.
Data Access Request Process
To facilitate data sharing, Researchers can submit a Data Access Request to gain access to data and samples from API trials and studies. Screening and longitudinal data, neuroimaging data, and biospecimens are available to request through API’s partnered sharing platforms and repositories. For more detail on data and samples available, please see the study specific pages.
Here's how it works:
Sample Access Request Process
To facilitate sample sharing, Researchers can submit a Sample Access Request to gain access to data and samples from API trials and studies. Biospecimens are available to request through API’s partnered sharing platforms and repositories. To learn more about submitting a request and what resources are available, please refer to the study specific pages.